Research collaboration opportunity investigating whether soil enrichment with malic acid boosts beneficial microbe biofilm formation, thereby enhancing plant carbon sequestration under elevated CO2 conditions, with applications in sustainable agriculture and climate mitigation.
This research explores a novel strategy for enhancing soil carbon sequestration by enriching soil with malic acid (MA), a natural compound found in plant seed and root exudates. The central hypothesis is that MA enrichment increases biofilm formation among beneficial soil microbes, which in turn enhances the ability of plants to assimilate and sequester atmospheric carbon. Preliminary work has demonstrated that MA at 0.5% concentration increases biofilm formation in Bacillus amyloliquefaciens ALB629, a beneficial bacterium shown to improve carbon sequestration in common bean plants. The research also investigates whether elevated atmospheric CO2 amplifies this effect, offering a potential dual-benefit approach for sustainable agriculture and climate change mitigation.
Research approach:
Key scientific basis:
This research is at an early experimental stage (TRL 2-3), building on validated preliminary findings that MA enrichment increases biofilm formation in a specific beneficial bacterium. The current proposal seeks to expand these findings to a broader microbiome context, identifying which bacterial and fungal taxa respond to MA enrichment with enhanced biofilm production and carbon sequestration. Future work will isolate and characterize novel microbial candidates with superior biofilm-forming capabilities for potential agricultural application. The research is conducted at the University of Florida with available growth chamber infrastructure and CO2 monitoring capabilities.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.